118 related articles for article (PubMed ID: 11187165)
1. [Hereditary warfarin resistance].
Lappegård KT
Tidsskr Nor Laegeforen; 2000 Nov; 120(27):3257-8. PubMed ID: 11187165
[TBL] [Abstract][Full Text] [Related]
2. An algorithm for managing warfarin resistance.
Osinbowale O; Al Malki M; Schade A; Bartholomew JR
Cleve Clin J Med; 2009 Dec; 76(12):724-30. PubMed ID: 19952297
[TBL] [Abstract][Full Text] [Related]
3. Dosing options for decreasing the time to achieve therapeutic anticoagulation when reinitiating warfarin: a case series.
Schultz KT; Bungard TJ
Pharmacotherapy; 2011 Aug; 31(8):793-805. PubMed ID: 21923606
[TBL] [Abstract][Full Text] [Related]
4. Effect of eslicarbazepine acetate on the steady-state pharmacokinetics and pharmacodynamics of warfarin in healthy subjects during a three-stage, open-label, multiple-dose, single-period study.
Vaz-da-Silva M; Almeida L; Falcão A; Soares E; Maia J; Nunes T; Soares-da-Silva P
Clin Ther; 2010 Jan; 32(1):179-92. PubMed ID: 20171423
[TBL] [Abstract][Full Text] [Related]
5. Oral anticoagulant initiation: rationale for the use of warfarin dosing nomograms.
Crowther MA
Semin Vasc Med; 2003 Aug; 3(3):255-60. PubMed ID: 15199458
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of factor II and factor X as therapeutic markers in patients under chronic warfarin therapy.
Costa IM; Serralheiro AI; Rodrigues M; Alves G; Falcão AC
Biomed Pharmacother; 2010 Feb; 64(2):130-2. PubMed ID: 20045627
[TBL] [Abstract][Full Text] [Related]
7. The effect of acetaminophen on the international normalized ratio in patients stabilized on warfarin therapy.
Parra D; Beckey NP; Stevens GR
Pharmacotherapy; 2007 May; 27(5):675-83. PubMed ID: 17461702
[TBL] [Abstract][Full Text] [Related]
8. Effect of acetaminophen on international normalized ratio in patients receiving warfarin therapy.
Hughes GJ; Patel PN; Saxena N
Pharmacotherapy; 2011 Jun; 31(6):591-7. PubMed ID: 21923443
[TBL] [Abstract][Full Text] [Related]
9. The effect of rofecoxib on the pharmacodynamics and pharmcokinetics of warfarin.
Schwartz JI; Bugianesi KJ; Ebel DL; De Smet M; Haesen R; Larson PJ; Ko A; Verbesselt R; Hunt TL; Lins R; Lens S; Porras AG; Dieck J; Keymeulen B; Gertz BJ
Clin Pharmacol Ther; 2000 Dec; 68(6):626-36. PubMed ID: 11180023
[TBL] [Abstract][Full Text] [Related]
10. Relationship between international normalized ratio values, vitamin K-dependent clotting factor levels and in vivo prothrombin activation during the early and steady phases of oral anticoagulant treatment.
D'Angelo A; Della Valle P; Crippa L; Fattorini A; Pattarini E; Viganò D'Angelo S
Haematologica; 2002 Oct; 87(10):1074-80. PubMed ID: 12368163
[TBL] [Abstract][Full Text] [Related]
11. Potential glucosamine-warfarin interaction resulting in increased international normalized ratio: case report and review of the literature and MedWatch database.
Knudsen JF; Sokol GH
Pharmacotherapy; 2008 Apr; 28(4):540-8. PubMed ID: 18363538
[TBL] [Abstract][Full Text] [Related]
12. Older age is risk for an international normalized ratio (INR) of 5 or more.
Ribak G; Barak M; Froom P
Clin Lab; 2007; 53(9-12):571-4. PubMed ID: 18257463
[TBL] [Abstract][Full Text] [Related]
13. Warfarin-cranberry juice interaction.
Hamann GL; Campbell JD; George CM
Ann Pharmacother; 2011 Mar; 45(3):e17. PubMed ID: 21364039
[TBL] [Abstract][Full Text] [Related]
14. Lack of effect of influenza immunisation on anticoagulant control in patients on long-term warfarin.
MacCallum P; Madhani M; Mt-Isa S; Ashby D
Pharmacoepidemiol Drug Saf; 2007 Jul; 16(7):786-9. PubMed ID: 17111459
[TBL] [Abstract][Full Text] [Related]
15. Relationship between chromogenic factor X and international normalized ratio differs during early warfarin initiation compared with chronic warfarin administration.
Rosborough TK; Jacobsen JM; Shepherd MF
Blood Coagul Fibrinolysis; 2009 Sep; 20(6):433-5. PubMed ID: 19543077
[TBL] [Abstract][Full Text] [Related]
16. Elevated international normalized ratio associated with use of dronedarone and warfarin.
Pogge EK; Haber SL
Ann Pharmacother; 2011 Sep; 45(9):e46. PubMed ID: 21811004
[TBL] [Abstract][Full Text] [Related]
17. Increased warfarin doses and decreased international normalized ratio response after nationwide generic switching.
Halkin H; Shapiro J; Kurnik D; Loebstein R; Shalev V; Kokia E
Clin Pharmacol Ther; 2003 Sep; 74(3):215-21. PubMed ID: 12966365
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of warfarin among patients with cancer.
Rose AJ; Sharman JP; Ozonoff A; Henault LE; Hylek EM
J Gen Intern Med; 2007 Jul; 22(7):997-1002. PubMed ID: 17476542
[TBL] [Abstract][Full Text] [Related]
19. Single-dose adjustment versus no adjustment of warfarin in stably anticoagulated patients with an occasional international normalized ratio (INR) out of range.
Schulman S; Melinyshyn A; Ennis D; Rudd-Scott L
Thromb Res; 2010 May; 125(5):393-7. PubMed ID: 19640572
[TBL] [Abstract][Full Text] [Related]
20. Warfarin induction at 5 mg daily is safe with a low risk of anticoagulant overdose: results of an audit of patients with deep vein thrombosis commencing warfarin.
Harper P; Monahan K; Baker B
Intern Med J; 2005 Dec; 35(12):717-20. PubMed ID: 16313547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
